NCT05596695

Brief Summary

Intraoperative hypotension is associated with postoperative nausea and vomiting (PONV). Even though the exact mechanism linking PONV and hypotension is still unclear, a reduced intestinal tissue perfusion might trigger nausea and vomiting. Still to date only limited data evaluating intraoperative blood pressure and the incidence of PONV after general anesthesia exits. Furthermore, the effect of intraoperative blood pressure variability on the incidence of PONV has not been investigated yet. Therefore, we will test our primary hypothesis that the incidence of PONV during the early (0-2h) postoperative period will be minimized by targeting intraoperative blood pressure variability to a SPB of 120±5mmHg by using a continuous vasopressor infusion in female patients undergoing elective minor to moderate risk non-cardiac surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
272

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

October 24, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 27, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

July 11, 2023

Status Verified

July 1, 2023

Enrollment Period

3 years

First QC Date

October 24, 2022

Last Update Submit

July 7, 2023

Conditions

Keywords

Blood Pressure VariabilityMinor- to moderate-risk noncardiac surgery

Outcome Measures

Primary Outcomes (1)

  • PONV

    Incidence of postoperative nausea and vomiting within the first two postoperative hours.

    First two postoperative hours

Secondary Outcomes (3)

  • Secondary Outcome 1: Late PONV

    First three postoperative days

  • Secondary Outcome 2: Modified Aldrete Score

    First two postoperative hours

  • Secondary Outcome 3: Ready for Hospital Discharge Scale

    First three postoperative days

Other Outcomes (4)

  • Exploratory Outcome 1: Intraoperative cerebral oxygen saturation between study groups

    Throughout surgery

  • Exploratory Outcome 2: Intraoperative cerebral oxygen saturation between patients, who experienced PONV, and patients without PONV

    Throughout surgery and first two postoperative hours

  • Exploratory Outcome 3: Impact of Event Scale-Revised

    Before surgery

  • +1 more other outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

Intraoperative blood pressure management will be performed to maintain a systolic blood pressure of 120 ±5mmHg using a continuous infusion of a vasopressor starting at induction of anesthesia.

Other: Minimizing blood pressure variability

Standard of Care Group

NO INTERVENTION

Intraoperative blood pressure management will be performed according to local clinical standard of care.

Interventions

Intraoperative blood pressure management will be performed to maintain a systolic blood pressure of 120 ±5mmHg using a continuous infusion of a vasopressor starting at induction of anaesthesia.

Intervention Group

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women 18-50 years of age at time of surgery
  • ASA physical status I and II
  • Scheduled for elective minor or moderate risk non-cardiac surgery with expected time of surgery ≥1 hour

You may not qualify if:

  • Patients undergoing emergency surgery
  • Scheduled for pheochromocytoma surgery
  • Nausea and/or vomiting on the morning before surgery
  • Taking anti-emetic drugs
  • Pregnancy
  • Dysfunction of the vestibular system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Vienna

Vienna, 1090, Austria

RECRUITING

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Study Officials

  • Christian Reiterer, MD

    Medical University of Vienna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 24, 2022

First Posted

October 27, 2022

Study Start

October 1, 2022

Primary Completion

October 1, 2025

Study Completion

February 1, 2026

Last Updated

July 11, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

We will not share any individual participant data

Locations